125 related articles for article (PubMed ID: 20171779)
1. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur Urol; 2010 Aug; 58(2):275-80. PubMed ID: 20171779
[TBL] [Abstract][Full Text] [Related]
2. Hereditary aspects of prostate cancer.
McLellan DL; Norman RW
CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
[TBL] [Abstract][Full Text] [Related]
3. Age at diagnosis and age at death in familial prostate cancer.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
[TBL] [Abstract][Full Text] [Related]
4. Familial risk factors for prostate cancer.
Carter BS; Steinberg GD; Beaty TH; Childs B; Walsh PC
Cancer Surv; 1991; 11():5-13. PubMed ID: 1841757
[TBL] [Abstract][Full Text] [Related]
5. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
[TBL] [Abstract][Full Text] [Related]
6. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families.
Bock CH; Peyser PA; Montie JE; Cooney KA
Prostate; 2005 Jun; 64(1):60-6. PubMed ID: 15651090
[TBL] [Abstract][Full Text] [Related]
7. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
Grönberg H; Wiklund F; Damber JE
Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and completeness in reporting family history of prostate cancer by unaffected men.
Gaff CL; Aragona C; MacInnis RJ; Cowan R; Payne C; Giles GG; Lindeman GJ
Urology; 2004 Jun; 63(6):1111-6. PubMed ID: 15183962
[TBL] [Abstract][Full Text] [Related]
9. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer.
Schuurman AG; Zeegers MP; Goldbohm RA; van den Brandt PA
Epidemiology; 1999 Mar; 10(2):192-5. PubMed ID: 10069259
[TBL] [Abstract][Full Text] [Related]
10. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
Zeegers MP; Jellema A; Ostrer H
Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
[TBL] [Abstract][Full Text] [Related]
11. Familial aspects of prostate cancer: a case control study.
Keetch DW; Rice JP; Suarez BK; Catalona WJ
J Urol; 1995 Dec; 154(6):2100-2. PubMed ID: 7500468
[TBL] [Abstract][Full Text] [Related]
12. [Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers].
Villers A; Soulié M; Haillot O; Boccon-Gibod L
Prog Urol; 1997 Sep; 7(4):655-61. PubMed ID: 9410329
[TBL] [Abstract][Full Text] [Related]
13. Familial prostate cancer in Sweden. A nationwide register cohort study.
Grönberg H; Damber L; Damber JE
Cancer; 1996 Jan; 77(1):138-43. PubMed ID: 8630920
[TBL] [Abstract][Full Text] [Related]
14. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
[TBL] [Abstract][Full Text] [Related]
15. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
Sun L; Caire AA; Robertson CN; George DJ; Polascik TJ; Maloney KE; Walther PJ; Stackhouse DA; Lack BD; Albala DM; Moul JW
J Urol; 2009 Nov; 182(5):2242-8. PubMed ID: 19758616
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
17. Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
Elkins DA; Yokomizo A; Thibodeau SN; J Schaid D; Cunningham JM; Marks A; Christensen E; McDonnell SK; Slager S; J Peterson B; J Jacobsen S; R Cerhan J; L Blute M; J Tindall D; Liu W
Prostate; 2003 Jun; 56(1):30-6. PubMed ID: 12746844
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
[TBL] [Abstract][Full Text] [Related]
19. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
20. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
